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ABSTRACT
Background: Haemoptysis is a common clinical symp-
tom. A small proportion of patients present with
haemoptysis and normal chest radiograph. The investi-
gation strategy for this group of patients is unclear. The
aim of this study is to see whether further investigations
for this group of patients are justified.
Methods: A retrospective analysis was conducted of
consecutive patients presenting with haemoptysis and
normal chest radiograph over a period of 56 months
irrespective of their smoking status. These patients were
investigated by CT of the thorax and fibreoptic bronchoscopy.
Results: 275 episodes of haemoptysis with normal chest
radiograph were investigated further in 270 patients (60%
males). The median age was 60 years. Twenty-six
patients were diagnosed to have respiratory tract
malignancies (larynx, 1; trachea, 1; lung, 22; carcinoid, 1;
and leiomyoma, 1). Eight (31%) of the 26 patients with
respiratory tract malignancy had radical treatment.
Fibreoptic bronchoscopy was diagnostic of cancer in 14
(54%) of the 26 patients with malignancy. CT of the
thorax was suggestive of cancer in 24 (96%) of the 25
patients with malignancy.
Conclusion: It is concluded that further investigation of
haemoptysis in smokers is justified regardless of the
amount or frequency of haemoptysis based on a 9.6%
rate of malignancy in this consecutive series. It is
recommended that these patients are investigated with
CT of the thorax followed by fibreoptic bronchoscopy.
Haemoptysis is a common and worrying clinical
symptom. It is potentially life threatening and
warrants further investigation. Haemoptysis can
be due to varying aetiologies including lung
cancer.
1 The optimal strategy for investigating
patients with haemoptysis and normal chest
radiograph (CXR) is unclear. Doctors tend to
investigate these patients differently.
The prognosis for lung cancer remains poor, with
5-year survival figures of 4–12% worldwide.
23 The
prospects for changing this are limited by a number
of factors including, most notably, the late presenta-
tion of patients with advanced disease and the lack
of convincing evidence for screening asymptomatic
individuals for lung cancer. Early diagnosis of lung
cancer is crucial to allow curative resection. Further
investigations of patients with haemoptysis and
normal CXR may lead to early diagnosis.
In this retrospective study we analysed a group
of patients with haemoptysis and normal CXR to
see whether further investigations were justified.
METHODS
We conducted a retrospective analysis of consecu-
tive patients presenting with haemoptysis and
normal CXR to Dewsbury and District Hospital,
West Yorkshire, UK between May 2001 and
December 2005. The catchment population of our
hospital is 175 000.
All patients presenting with haemoptysis and a
normal CXR were investigated further in line with
local guidance irrespective of their smoking status,
age, or quantity or frequency of haemoptysis. The
UK national guidelines
4 for management of lung
cancer recommend urgent CXR for patients pre-
senting with haemoptysis. In our local policy for
referral and management of lung cancer for general
practitioners (GPs) and general physicians, urgent
referral to chest physicians was advised for all
patients presenting with haemoptysis regardless of
the CXR result. The patients were either referred
from primary care locally or from secondary care in
our hospital.
The patients were identified from the urgent
suspected lung cancer referrals database and our
fibreoptic bronchoscopy (FOB) database. Patients
with abnormal CXR were excluded. The CXR
should have been reported normal by a radiologist
or documented to be normal in medical notes by a
chest physician. The outpatient CXRs are reported
by our radiologists as a standard practice.
These patients were routinely investigated
further by CT of the thorax, FOB as well as
history, clinical examination and blood investiga-
tions. The standard CT procedure in our institu-
tion for lung cancer staging during the study period
was contrast-enhanced contiguous 5 mm sections
from lung apices to the liver and adrenal glands.
FOB is performed either by the chest physician or
by supervised trainees. From the clinical records the
following variables were collected: age, sex, smoking
history, comorbidities, symptoms (eg, chest pain,
weight loss), quantity/nature (streak, teaspoonful,
tablespoonful), frequency and duration of haemop-
tysis (onceonly, recurrent lasting uptoor morethan
1 week), history of chronic sputum production
when available and the final diagnosis based on
clinical, radiology and histology findings.
RESULTS
A total of 275 episodes of haemoptysis with
normal CXR were investigated further in 270
patients (60% males). The median age was 60
years (interquartile range 22 years); 10% were
under the age of 40. Ninety percent of these
patients were either active smokers (156) or ex
smokers (90). The details of the nature and
frequency of haemoptysis are as listed in table 1.
The details of associated symptoms and comorbid-
ities are listed in table 2. FOB was performed in 269
patients (98%). CT was performed in 257 patients
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Diagnoses of respiratory tract neoplasias and other diagnoses
achieved are as listed in tables 4 and 5, respectively.
Overall, 26 (9.6%) patients were diagnosed to have respira-
tory tract malignancy. Nine (35%) of the 26 patients with
repiratory tract malignancy were suitable for radical treatment.
Eight (31%) of the 26 patients with respiratory tract malignancy
had radical treatment. One patient with T2N0M0 non-small
cell lung cancer refused radical treatment. Six patients had
curative surgical resection (lung, 5; trachea, 1), one had radical
radiotherapy and one had photodynamic therapy (PDT). Four
other patients underwent surgical resection for probable
malignancy, but the final histology showed suture granuloma
(1), aspergilloma (1) and organising pneumonia (2). Two
patients were diagnosed to have papillary carcinoma of the
thyroid and lymphoma incidentally. One patient required
embolisation for life-threatening haemoptysis of unknown
cause.
Nineteen patients were diagnosed to have malignancy in the
28 patients with bronchoscopy findings suspicious of malig-
nancy (lung, 17; trachea, 1; and larynx, 1). Follow-up
bronchoscopies were required in one patient and lung cancer
was diagnosed only on the third occasion. Two patients with
squamous metaplasia had serial autofluorescence bronchosco-
pies which ruled out malignancy. FOB was diagnostic of cancer
in 14 (54%) of the 26 patients with respiratory tract malignancy
(one patient declined FOB).
Twenty-four cancers were diagnosed in the 30 patients who
had CT findings suspicious of cancer. Among the 57 patients
with abnormal CT scan not suggestive of malignancy, 30 did
show unsuspected pulmonary pathology to explain the hae-
moptysis (bronchiectasis, 16; pneumonia, 11; leiomyoma, 1;
pulmonary embolism and bronchiectasis, 1; tuberculosis, 1).
The patient with laryngeal carcinoma did not have a CT due to
the suspicion of laryngeal cancer at bronchoscopy which was
later confirmed by the Ear, Nose and Throat (ENT) surgeons.
CT was suggestive of cancer in 24 (96%) of the 25 patients with
respiratory tract malignancy (the patient with laryngeal cancer
was referred to the ENT team after bronchoscopy without CT).
Investigations carried out following CT and FOB in 16 patients
(20 procedures) are listed in table 6.
Among the 26 patients diagnosed to have respiratory tract
malignancy in our study, 22 were males (85%) and smokers
with an average of 38 pack-years. The median age of these
patients was 69 years with age range 33–84 years. Thirteen of
these patients reported only streak(s) of haemoptysis. Thirteen
patients had only one or two episodes of haemoptysis in total
prior to presentation. Seventeen of these patients had haemop-
tysis lasting less than a week. Only 5 of the 26 patients had
recurrent haemoptysis of at least a tablespoonful.
DISCUSSION
In this retrospective study 9.6% of patients were diagnosed to
have respiratory tract malignancy. In spite of our local policy, all
the patients who presented with haemoptysis may not have
been referred to us, leading to selection bias. Previous studies
found a 0–16% cancer detection rate in patients presenting with
haemoptysis and normal CXR.
5–10
Haemoptysis is the presenting symptom in up to 19% of the
patients with lung cancer.
11 Poe et al found that coughing up .
30 ml of blood increased the diagnostic yield.
12 In our study only
5 patients with lung cancer had a tablespoonful, recurrent
haemoptysis, and more than half of the patients had only
streak(s) with infrequent episodes of haemoptysis lasting less
than a week. Fidan et al reported in a retrospective analysis of
patients presenting with haemoptysis that just over 40% of
patients with lung cancer presented with mild and non-
recurrent haemoptysis.
13
Some studies looked at whether patients above a particular
age should be investigated. Sood et al analysed all the studies
published so far and concluded that age above 50, male sex and
smokers of 40 pack-years had the highest predictive value for
bronchogenic carcinoma.
14 In contrast, Cortese et al reported
radiologically occult lung cancer in 5.5% of patients who were
,50 years old.
15 A primary care cohort study reported higher
Table 1 Nature and frequency of haemoptysis in patients
Nature of
haemoptysis
No. of
patients
(percentage)
Frequency of haemoptysis
Once
only
Less than a
week
One week
or more
Not
known
Streaks 165 (60%) 54 85 23 3
Teaspoonful 52 (18.9%) 10 33 8 1
Tablespoonful 39 (14.2%) 10 24 4 1
Egg cup full 1 (0.4) 1 0 0 1
Not specified 18 (6.5%) 8 2 5 3
Table 2 Associated symptoms and co-morbidities in patients
No. of patients (percentage)
Symptoms
Weight loss 11 (4%)
Chest pain 11 (4%)
Cough 195 (71%)
Purulent sputum 41 (15%)
Comorbidities
Ischaemic heart disease 30 (10.9%)
Chronic obstructive pulmonary disease 32 (11.6)
Hypertension 15 (5.4%)
Asthma 12 (4.3%)
Diabetes 9 (3.2%)
Table 3 Cross-tabulation of CT and bronchoscopy results in patients
CT scan results
Normal ?Malignancy
Benign
changes Not done
Bronchoscopy results
Normal 158 11* 49 15
?Malignancy{ 01 3 1 0
?Malignancy{ 46 3 1
Benign changes 4 0 4 0
Not done 3 11 10
Data are presented as numbers. Bronchoscopy, n=269; CT, n=257.
*Final diagnosis of malignancy made in 10 patients.
{Confirmed to be malignancy in bronchoscopy samples.
{Benign pathology diagnosed from bronchoscopy samples.
1Clinical diagnosis of lung malignancy.
Table 4 Respiratory tract neoplasias diagnosed
Non-small cell carcinoma 20
Small cell carcinoma 2
Laryngeal carcinoma 1
Tracheal paraganglioma 1
Carcinoid 1
Leiomyoma 1
Data are presented as numbers (n=26)
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years when they present with haemoptysis irrespective of CXR
appearance.
16 The median age of patients with lung cancer in
our study is 69 years with male predominance (85%).
Both FOB and CT have definite important roles in evaluating
haemoptysis in patients with abnormal CXR for bronchogenic
carcinoma. A lung cancer detection rate of up to 21% with
bronchoscopy alone in patients with haemoptysis and normal
CXR has been reported.
17–20 Prospective studies by Tak et al and
Haro et al indicate that FOB and CT are complementary,
irrespective of CXR findings.
62 12 2 Even though FOB is a
relatively straightforward procedure it still carries a small risk.
In a long-term outcome study of patients with haemoptysis
of unknown aetiology Herth et al reported that 6% of patients
developed lung cancer over a mean follow-up period of 6.6
years.
23 Santiago et al reported 4% of patients developing lung
cancer over a 6-year period when the initial investigations were
inconclusive.
24 All these patients were smokers and .40 years of
age. In our study, one patient developed lung cancer after a
follow-up period of 20 months. The mean follow-up period in
our study population was 36 months.
As far as we are aware, this study reports the largest group of
consecutive patients with haemoptysis and normal CXR who
were investigated with CT and FOB. Our study demonstrates
the importance of investigating such patients. However, our
study is retrospective and the characteristics of the patient
population prevent us from making recommendations with
respect to non-smokers, females or younger people.
CONCLUSION
Haemoptysis is a valuable diagnostic clue to resectable lung
cancer. More frequently haemoptysis is likely to be secondary to
benign pulmonary pathology. Bronchoscopy is invasive; radia-
tion is a safety concern of CT, particularly in young people. CT
has the advantage of being more sensitive in diagnosing distant
bronchial and parenchymal abnormalities, but FOB is better in
evaluating mucosal abnormalities and providing material for
pathological diagnosis. CT or bronchoscopy could fail to detect
abnormalities when the other modality did, as seen in this
study. Even though CT and bronchoscopy are complementary,
CT is more likely to detect abnormalities to explain the cause of
haemoptysis.
We conclude that further investigation of haemoptysis in
smokers with a normal CXR is justified regardless of the
amount or frequency of haemoptysis based on a 9.6% rate of
malignancy in our consecutive series. We recommend that these
patients are investigated with CT followed by bronchoscopy.
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Lymphoma 1
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Suture granuloma 1
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Data are presented as numbers (n=275).
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CT-guided biopsy 1
Follow-up CT 10
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Data are presented as numbers (n=20).
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